NOW APPROVED

Power
Reimagined

Indication
DOVATO is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of DOVATO.

Not an actual patient

Indication
DOVATO is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of DOVATO.

Discover Dovato

CLINICAL TRIALS

GEMINI 1 & 2—2 identically designed, Phase 3 trials in treatment-naïve adults

SEE DATA

Read more »

DOSING

Dosing and administration for your treatment-naïve adult patients with HIV-1

LEARN MORE

Read more »

POWER REIMAGINED

DOVATO is POWER REIMAGINED for your newly diagnosed adult patients with HIV-1

WATCH VIDEO

Read more »

A deeper Look at DOVATO

MECHANISM OF ACTION VIDEO

DOVATO inhibits the viral life cycle at 2 separate sites like a traditional 3-drug regimen

Read more »

REQUEST A ViiV REPRESENTATIVE

Have questions about DOVATO? Speak with a ViiV Representative in person

Read more »

DLLWCNT190014